MTCAX
Price
$70.15
Change
+$0.52 (+0.75%)
Updated
Jul 31 closing price
Net Assets
2.29B
SCIRX
Price
$202.27
Change
+$0.86 (+0.43%)
Updated
Jul 31 closing price
Net Assets
27.54B
Interact to see
Advertisement

MTCAX vs SCIRX

MTCAX vs SCIRX Comparison Chart in %
View a ticker or compare two or three
VS
MTCAX vs. SCIRX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTCAX is a Buy and SCIRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCIRX has more cash in the bank: 27.5B vs. MTCAX (2.3B). MTCAX (0.00) and SCIRX (0.00) have matching dividends . MTCAX was incepted earlier than SCIRX: MTCAX (30 years) vs SCIRX (23 years). SCIRX (1.41) is less costly to investors than MTCAX (1.12). MTCAX is a more actively managed with annual turnover of: 50.00 vs. SCIRX (33.00). SCIRX has a lower initial minimum investment than MTCAX: SCIRX (0) vs MTCAX (1000). SCIRX annual gain was more profitable for investors over the last year : 64.29 vs. MTCAX (4.84). SCIRX return over 5 years is better than : 70.46 vs. MTCAX (-4.25).
MTCAXSCIRXMTCAX / SCIRX
Total Expense Ratio1.111.4179%
Annual Report Gross Expense Ratio1.121.4179%
Fund Existence30 years23 years-
Gain YTD13.23646.03329%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.3B27.5B8%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.8464.298%
Returns for 3 years34.5299.2235%
Returns for 5 years-4.2570.46-6%
Returns for 10 years154.17263.1459%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AAAA30.030.15
+0.49%
Amplius Aggressive Asset Allocation ETF
DON57.52-0.05
-0.09%
WisdomTree US MidCap Dividend ETF
AVSD81.18-0.50
-0.62%
Avantis Responsible International Eq ETF
LIAU252.82-3.16
-1.23%
LifeX 2060 Infl-Prt Longevity Income ETF
GNOM54.17-1.22
-2.21%
Global X Genomics & Biotechnology ETF